IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,824,833 | +10.6% | 40,230 | 0.0% | 0.10% | +12.1% |
| Q2 2023 | $1,650,637 | +14.8% | 40,230 | 0.0% | 0.09% | +9.6% |
| Q1 2023 | $1,437,820 | -5.4% | 40,230 | 0.0% | 0.08% | -13.5% |
| Q4 2022 | $1,519,487 | -14.6% | 40,230 | 0.0% | 0.10% | -16.5% |
| Q3 2022 | $1,779,000 | +17.2% | 40,230 | -1.9% | 0.12% | +23.7% |
| Q2 2022 | $1,518,000 | -0.1% | 41,010 | 0.0% | 0.09% | +29.2% |
| Q1 2022 | $1,519,000 | +23.0% | 41,010 | +1.1% | 0.07% | +38.5% |
| Q4 2021 | $1,235,000 | -9.3% | 40,580 | 0.0% | 0.05% | -22.4% |
| Q3 2021 | $1,361,000 | -15.9% | 40,580 | 0.0% | 0.07% | -17.3% |
| Q2 2021 | $1,619,000 | -14.4% | 40,580 | -3.6% | 0.08% | -22.9% |
| Q1 2021 | $1,892,000 | -20.5% | 42,080 | 0.0% | 0.10% | -24.5% |
| Q4 2020 | $2,379,000 | +19.1% | 42,080 | 0.0% | 0.14% | +3.0% |
| Q3 2020 | $1,997,000 | -14.0% | 42,080 | +6.9% | 0.14% | -20.1% |
| Q2 2020 | $2,322,000 | +24.7% | 39,380 | 0.0% | 0.17% | +14.2% |
| Q1 2020 | $1,862,000 | -21.7% | 39,380 | 0.0% | 0.15% | -6.3% |
| Q4 2019 | $2,379,000 | +0.8% | 39,380 | 0.0% | 0.16% | -4.2% |
| Q3 2019 | $2,359,000 | -6.8% | 39,380 | 0.0% | 0.16% | -2.9% |
| Q2 2019 | $2,531,000 | -29.7% | 39,380 | -11.3% | 0.17% | -35.4% |
| Q1 2019 | $3,602,000 | +53.6% | 44,380 | +2.3% | 0.26% | +34.9% |
| Q4 2018 | $2,345,000 | +4.8% | 43,380 | 0.0% | 0.20% | +25.0% |
| Q3 2018 | $2,238,000 | +23.8% | 43,380 | 0.0% | 0.16% | +13.0% |
| Q2 2018 | $1,808,000 | -3.2% | 43,380 | +2.4% | 0.14% | -8.6% |
| Q1 2018 | $1,868,000 | -10.0% | 42,380 | +2.7% | 0.15% | -11.7% |
| Q4 2017 | $2,076,000 | -0.8% | 41,280 | 0.0% | 0.17% | -8.6% |
| Q3 2017 | $2,093,000 | -0.3% | 41,280 | 0.0% | 0.19% | -2.1% |
| Q2 2017 | $2,100,000 | +37.3% | 41,280 | +8.5% | 0.19% | +30.8% |
| Q1 2017 | $1,529,000 | -14.8% | 38,030 | +1.3% | 0.15% | -21.5% |
| Q4 2016 | $1,795,000 | +30.5% | 37,530 | 0.0% | 0.19% | +51.2% |
| Q3 2016 | $1,375,000 | +107.1% | 37,530 | +31.5% | 0.12% | +101.6% |
| Q2 2016 | $664,000 | -11.0% | 28,530 | +54.8% | 0.06% | -9.0% |
| Q1 2016 | $746,000 | -33.1% | 18,430 | +2.4% | 0.07% | +13.6% |
| Q4 2015 | $1,115,000 | – | 18,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |